Ampersand Capital’s Investment in P95

Quinz advised Ampersand Capital on its investment. P95 BV, a global provider of epidemiology and clinical research solutions focused on vaccines and infectious diseases, has announced...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Fronnt’s Acquisition of Climawest

Quinz advised Fronnt on the deal. Fronnt (a portfolio company of Gimv) announced the acquisition of Climawest, a specialist in HVAC techniques and sanitary. This acquisition...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Savaco’s Acquisition of TrueGEN

Quinz advised the shareholders of TrueGEN on the deal. The shareholders of TrueGEN completed the sale of their shares to Savaco. TrueGEN offers custom-built network security...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here